Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Linda McAllister, Mostafa Ronaghi

Premium

Linda McAllister has joined Toronto-based molecular diagnostics firm Xagenic as chief medical officer.

McAllister previously has worked on the development and launch of molecular technologies at Roche Diagnostics, Celera Diagnostics, and Affymetrix. She most recently was CMO at the prenatal genetic testing company Cellscape, and she was CMO and VP of R&D at Pharmajet. She also was an adjunct clinical professor in the University of California, San Francisco department of medicine from 1992 to 2005, and a research fellow at Stanford University.


Mostafa Ronaghi has joined BaseHealth's board of directors.

Ronaghi currently serves as Illumina's chief technology officer and senior vice president. Before joining Illumina, he founded several life sciences companies including ParAllele BioScience, which was acquired by Affymetrix, as well as Avantome and NextBio, both of which were acquired by Illumina. He also previously spent nine years as a principal investigator at the Stanford Genome Technology Center.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.